These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27612430)
21. Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Huang S; He X; Ding J; Liang L; Zhao Y; Zhang Z; Yao X; Pan Z; Zhang P; Li J; Wan D; Gu J Int J Cancer; 2008 Aug; 123(4):972-8. PubMed ID: 18508316 [TBL] [Abstract][Full Text] [Related]
22. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Fransvea E; Angelotti U; Antonaci S; Giannelli G Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443 [TBL] [Abstract][Full Text] [Related]
23. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway. Zhu M; Li W; Lu Y; Dong X; Lin B; Chen Y; Zhang X; Guo J; Li M Int J Cancer; 2017 Mar; 140(6):1346-1355. PubMed ID: 27925189 [TBL] [Abstract][Full Text] [Related]
24. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells. Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807 [TBL] [Abstract][Full Text] [Related]
25. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
27. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway. Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046 [TBL] [Abstract][Full Text] [Related]
28. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122 [TBL] [Abstract][Full Text] [Related]
29. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells. Caja L; Sancho P; Bertran E; Fabregat I J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185 [TBL] [Abstract][Full Text] [Related]
30. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064 [TBL] [Abstract][Full Text] [Related]
31. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways. Lin SJ; Chang C; Ng AK; Wang SH; Li JJ; Hu CP Apoptosis; 2007 Sep; 12(9):1659-70. PubMed ID: 17624592 [TBL] [Abstract][Full Text] [Related]
32. Modulation of miR‑122 expression affects the interferon response in human hepatoma cells. Li A; Qian J; He J; Zhang Q; Zhai A; Song W; Li Y; Ling H; Zhong Z; Zhang F Mol Med Rep; 2013 Feb; 7(2):585-90. PubMed ID: 23241652 [TBL] [Abstract][Full Text] [Related]
33. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression. Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862 [TBL] [Abstract][Full Text] [Related]
34. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway. Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157 [TBL] [Abstract][Full Text] [Related]
35. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration. Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220 [TBL] [Abstract][Full Text] [Related]
36. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Liu ZM; Tseng JT; Hong DY; Huang HS Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584 [TBL] [Abstract][Full Text] [Related]
37. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034 [TBL] [Abstract][Full Text] [Related]
38. Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma. Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sakitani K; Yamashiki N; Seki T; Saito H; Nishizawa M; Fujisawa J; Inoue K Cancer Res; 2000 Mar; 60(5):1394-402. PubMed ID: 10728705 [TBL] [Abstract][Full Text] [Related]
39. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Wang X; He H; Lu Y; Ren W; Teng KY; Chiang CL; Yang Z; Yu B; Hsu S; Jacob ST; Ghoshal K; Lee LJ Biochim Biophys Acta; 2015 Jan; 1853(1):244-53. PubMed ID: 25447674 [TBL] [Abstract][Full Text] [Related]
40. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells. Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]